Search

Search Results

• Optimal First-Line Use of Pembrolizumab in Metastatic Driver-Negative NSCLC: Monotherapy Versus Chemo-Immunotherapy (Evidence 2022–2025)

  Patryk Bachurski, Gabriela Chmiel, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek, Elisabetta Pierzga, Karol Wiśniewski, Paweł Witkowski, Bartosz Zarański

  68252

  2026-01-31
• Efficacy of Olaparib in Women With BRCA2-Mutated Breast Cancer: A Critical Review of Clinical Evidence

  Bartosz Zarański, Patryk Bachurski, Gabriela Chmiel, Paweł Kalinowski, Maja Międlar, Martyna Muda, Szymon Pacek , Elisabetta Pierzga, Karol Paweł Wiśniewski, Paweł Witkowski

  76517

  2026-11-06
• Metformin and Physical Activity: Potential Interactions, Molecular Mechanisms and Implications for Lung Cancer Treatment- A Narrative Review

  Kacper Ponikowski, Eliza Kuchta, Kacper Wrzosek, Anna Rudzińska, Emilia Kamizela, Natalia Kowalczyk, Zuzanna Kowalczyk, Piotr Kowalewski, Karina Udrycka, Marcelina Szerej, Halina Piecewicz-Szczęsna

  73115

  2026-07-12
• Targeted Therapy in NSCLC: A Comprehensive Review of Molecular Drivers and Treatment Strategies

  Valeryia Milasheuskaya, Katsiaryna Miraniuk, Mykola Sobchynskyi , Andrii Myrnyi , Dmytro Kowalczuk , Viktoryia Kasianik , Darya Lazitskaya , Kamil Turlej , Iga Kiełbaszewska , Natalia Surosz , Dawid Wiczkowski

  61191

  2025-07-01